For example, insulin growth factor-1 (IGF-1) has an anabolic effect on various tissues, including the CNS and muscle, and there is some evidence that enhancing IGF-1 signaling could be beneficial in SMA.102. This evidence concerns the gene IGF1 and proximal spinal muscular atrophy.